COVID-19 update: The AVAMS organising committee has decided that the best option for everyone’s safety and surety that AVAMS has been delayed until 21-23rd November 2021, at the Intercontinental Sanctuary Cove on the Gold Coast, QLD. If you have already registered you will be contacted and have your registration rolled over unless otherwise arranged. Dates for abstracts and early bird registration have been amended below. If you have any questions, please don’t hesitate to get in contact with us

Chair's Welcome

On behalf of the organising committee, I am pleased to invite you to the 2nd Australian Veterinary Antimicrobial Stewardship Conference (AVAMS21), being held at the Intercontinental Sanctuary Cove from the 21-23rd November 2021. This conference will provide those who manage animal health in all sectors the opportunity to contribute to, and learn about, the growing number of antimicrobial stewardship initiatives underway in Australia and develop collaborative opportunities to strengthen these initiatives and address barriers that impede further progress in antimicrobial stewardship.

Australian approaches to the appropriate use of antimicrobials in animals have always had their basis in the principles of antimicrobial stewardship and lead the world in many of these initiatives. However, there is more that can be done to capture current efforts and clarify areas that require further progress. All animal sectors have the dual responsibilities of minimising the development of antimicrobial resistance (AMR), while upholding our collective responsibility to ensure high standards of animal health and welfare are maintained. While the COVID-19 pandemic has shifted global focus to human health, we must continue to focus on making improvements in animal health to minimise the potential risks to animal and human health, such as AMR. The efficacy of antimicrobials to treat human bacterial infections, which are a common complication of respiratory diseases such as caused by COVID-19, is more important than it has been in a generation. We must ensure the animal sector is doing all it can to use antimicrobials responsibly to manage animal health and welfare while minimising its contribution to the AMR burden.

I look forward to welcoming you to the Gold Coast in 2021, where there will be plenty of opportunity to expand your professional network and hopefully leave the conference with a resolve to action changes in your sector.

Dr Kylie Hewson

Dr Kylie Hewson

Deputy Executive Director
Australian Chicken Meat Federation


Professor Paul Kelly
Australian Chief Medical Officer

Professor Paul Kelly is currently the Chief Medical Officer at the Australian Government Department of Health. A public health physician and epidemiologist by training, Professor Kelly has previously worked in research, health systems development, post-graduate teaching and as a health service executive. Professor Kelly is the Chair of the Australian Health Protection Principle Committee (AHPPC) and as an official member of National Cabinet, has contributed his extensive public health and epidemiological knowledge and experience in the formulation of various plans and advice relating to COVID-19.

Dr Mark Schipp
Australian Chief Veterinary Officer

Mark Schipp was appointed Australian Chief Veterinary Officer in 2011.  In 2012 he was elected to the OIE Council and in 2018 was elected President of the OIE General Assembly. Together with the Chief Medical Officer, Dr Schipp chairs the Australian Strategic and Technical Advisory Group on Antimicrobial Resistance. He is also a member of the Animal Health Committee.

Dr Shabbir Simjee
Chief Medical Officer at Elanco Animal Health

Dr Simjee is past-chair of the VetPath program a Pan European AMR monitoring program and past co-chair of the CLSI veterinary antimicrobial susceptibility testing sub-committee. He has served 9 years as editor for Journal of Antimicrobial Chemotherapy, 10 years as editor for Antimicrobial Agents and Chemotherapy and continues to serve as editor on International Journal of Antimicrobial Agents.
Dr Simjee is now chief Medical Officer at Elanco Animal Health with global responsibilities for Elanco’s antimicrobial portfolio.

Prof Rungtip
Professor Rungtip Chuanchuen
Head of the Research Unit on Microbial Food Safety and Antimicrobial Resistance, Chulalongkorn University.

Prof Rungtip is a veterinary professor at Faculty of Veterinary Science, Chulalongkorn University. She received her DVM from Chulalongkorn University and her MS in Animal Science and Ph.D in Microbiology from Colorado State University. She has been director of Center of Antimicrobial Resistance Monitoring in Foodborne Pathogens (in cooperation with WHO), Global Infections Network: South-East Asia and Western Pacific region and FAO Reference Center for Antimicrobial Resistance.

Dr Stephen Page
Advanced Veterinary Therapeutics

Stephen is a consultant veterinary clinical pharmacologist and toxicologist and founder and sole director of Advanced Veterinary Therapeutics, a consulting company that provides advice on appropriate use of veterinary medicines to veterinarians, veterinary organisations (Australian Veterinary Association, World Veterinary Association, World Organisation for Animal Health), state and national government departments and statutory bodies (APVMA, Department of Agriculture, Department of Health, US Environmental Protection Agency), and global organisations (OIE, FAO, Chatham House).

Professor Sabiha Essack
South African Research Chair in Antibiotic Resistance & One Health

Sabiha Essack is the South African Research Chair in Antibiotic Resistance and One Health and Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal. She serves as expert consultant on antimicrobial resistance to the World Health Organization and the International Centre for Antimicrobial Resistance Solutions in Denmark. She is chairperson of the Global Respiratory Infection Partnership, vice-chairperson of the AMR Ambassadors Network and serves on the Advisory Board of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).

Key Dates

  • Abstracts open 5 March 2020
  • Early bird registrations open 5 March 2020
  • Abstract submissions close 15 March 2021
  • Early bird registrations close 3 August 2021
  • Conference opens 21 November 2021



Full Registration
$ 695 In-Person
  • Virtual - $595


Full Registration
$ 350 In-Person
  • Virtual - $300

Cancellation Policy available here


Abstract Submissions have now closed.  Thank you to everyone who submitted an abstract.  All presenters have now been contacted and if you have any questions please email us at


Interested in Becoming a Sponsor?  Email us  to request a prospectus.





+ Student Travel Fellowship

Coffee Cart

Travel Fellowship


Nestled within 4.2 hectares of lush landscaping, InterContinental Sanctuary Cove Resort is home to a recently refreshed stay collection, a show-stopping one-acre Lagoon Beach, Queensland’s only High Coffee experience and signature service excellence. Positioned on the northern end of the Gold Coast, Sanctuary Cove unlocks unprecedented access to three championship golf courses and Sanctuary Cove Country Club, a world-class marina, the region’s famous theme parks and more. 

Intercon logo



Immerse yourself in the tranquillity of our Garden View rooms with views stretching across InterContinental Sanctuary Cove Resort’s 4.2 hectare tropical garden or the magnificent The Palms Golf Course. With fresh, contemporary décor blending indoor with outdoor, 37sqm rooms feature a spaciously-appointed retreat complete with the following:

  • Contemporary king or twin bed with gold-studded headboard and luxe linen bedding
  • Spacious bathroom with a deep bathtub and separate shower
  • Dedicated work zone with WiFi and iPod docking station
  • Siding shutters with private, furnished balcony
  • Polished wooden parquetry floors, air-conditioning and TV

$195/night, breakfast additional $20 pp/night when prebooked at time of registration.

AVAMS 2021 Conference Secretariat
Kate Murphy and Jenny Lawler
YRD Event Management

P 07 3368 2422 | F 07 3368 2433 | E
PO Box 717 Indooroopilly QLD 4068

Join our mailing list